SENSEONICS HOLDINGS INC (SENS)
US81727U1051 - Common Stock
SENSEONICS HOLDINGS INC
NYSEARCA:SENS (11/21/2024, 5:43:10 PM)
After market: 0.3167 -0.01 (-1.86%)0.3227
+0.01 (+1.7%)
Company Profile
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 132 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.
Company Info
SENSEONICS HOLDINGS INC
20451 Seneca Meadows Pkwy
Germantown MARYLAND 20876
P: 13015157260
CEO: Timothy T. Goodnow
Employees: 132
Website: https://www.senseonics.com/
SENS News
9 days ago - Senseonics Holdings, Inc.Senseonics Holdings, Inc. to Participate in Upcoming Investor ConferencesGERMANTOWN, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the...
13 days ago - ChartmillFriday's after hours session: top gainers and losersCurious about the stocks that are showing activity after the closing bell on Friday?
a month ago - Senseonics Holdings, Inc.Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering$16 million upfront with the potential for an additional $16 million upon the exercise in full of warrants...
a month ago - Senseonics Holdings, Inc.Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM SystemEvent featuring David T. Ahn, MD from Hoag Medical Group and Jeff Ciaramita, MD from Mercy health system, along with management...
a month ago - Senseonics Holdings, Inc.Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose MonitorSenseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes...
2 months ago - Senseonics Holdings, Inc.Eversense 365 Receives FDA Clearance: The World’s First One Year CGMEversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the...
SENS Twits
Here you can normally see the latest stock twits on SENS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
